1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Oesophageal cancer

Durvalumab with chemoradiation for untreated unresectable locally advanced oesophageal squamous cell cancer ID6490

Awaiting development [GID-TA11624] Expected publication date: TBC

  • Project information
  • Project documents

33917-Durvalumab-Chemoradiation-for-Oesophageal-Cancer-V1.0-AUG2024-NON-CONF.pdf (nihr.ac.uk)